The antiepidermal growth factor receptor agent gefitinib (ZD1839/Iressa) improves antihormone response and prevents development of resistance in breast cancer in vitro

Gee, Julia Margaret Wendy ORCID: https://orcid.org/0000-0001-6483-2015, Harper, ME, Hurcheson, IR and Madden, TA 2003. The antiepidermal growth factor receptor agent gefitinib (ZD1839/Iressa) improves antihormone response and prevents development of resistance in breast cancer in vitro. Endocrinology 144 (11) , pp. 5105-5117. 10.1210/en.2003-0705

Full text not available from this repository.

Item Type:	Article
Date Type:	Publication
Status:	Published
Schools:	Schools > Pharmacy
ISSN:	00137227
Last Modified:	17 Oct 2022 08:44
URI:	https://orca.cardiff.ac.uk/id/eprint/918

Citation Data

Cited 166 times in Scopus. View in Scopus. Powered By Scopus® Data

Actions (repository staff only)

Edit Item